MedTrace Logo

Safety and Effectiveness of High Frequency Electrocautery for Abdominal Fat Reduction

NCT06850246 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-03-03

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if the intervention of radiofrequency technology can help treat abdominal fat hypertrophy and skin laxity in adults. The main questions it aims to answer are

* Does radiofrequency technology lower the abdominal subcutaneous adipose tissue height by ultrasound measurement?
* Does radiofrequency technology improve abdominal circumference data and lower the number of times participants need to use a rescue inhaler.

Researchers will compare the treatment side to the non-treatment side to see if radiofrequency technology works to treat abdominal fat hypertrophy and skin laxity?

Participants will:

* Accept the treatment of radiofrequency technology every week for 10 weeks.
* Visit the clinic 1 month and 3 months after the treatment ends for checkups and tests.

Conditions

  • BMI

Interventions

DEVICE

treatment of radiofrequency technology

When operating, first select 470 kHz frequency, CRT resistance probe for deep fat management operation for 10 minutes, and then select CET capacitance mode 470 kHz for superficial fat operation for 6 minutes. Then, select the 940 kHz frequency CET capacitance probe for epidermal tightening operation for 4 minutes. The temperature is set by the energy value. In CRT mode, the energy value is set to 70, and it can reach above 42 ℃ within one minute. In CET mode, the energy value setting is adjusted to 75. The operation mode is to gradually raise the temperature to the midline after partially increasing the temperature at the side of the waist. The technique is mainly to move in a circle and lift to the midline.

DEVICE

Placebo

Under the condition that the machine is not turned on, the treatment is performed in the same operation time, mode, and treatment area of the treatment group.

Sponsors & Collaborators

  • Chinese Medical Association

    lead NETWORK

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-07-01
Primary Completion
2025-02-01
Completion
2025-04-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06850246 on ClinicalTrials.gov